Insider Shareholders with Direct Ownership of Indaptus Therapeutics, Inc. (INDP)
This section provides a comprehensive overview of the insiders with direct ownership of Indaptus Therapeutics, Inc. (INDP). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Indaptus Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jeffrey A Meckler
Co-Chief Executive Officer |
423,084 | 0 | 229,929 $577,121 | 12 |
Dec 22, 2025
Added 48.51%
|
|
Michael James Newman
CSO and Director |
52,204 | 0 | 101,074 $253,695 | 1 |
Dec 22, 2025
Added 34.06%
|
|
Walt Addison Linscott
Chief Operating Officer |
54,571 | 0 | 54,426 $136,609 | 2 |
Dec 22, 2025
Added 50.0%
|
|
Nir Sassi
Chief Financial Officer |
26,758 | 0 | 26,758 $67,162 | 1 |
Dec 22, 2025
Added 50.0%
|
|
Boyan Vesselinov Litchev
Chief Medical Officer |
1,150 | 0 | 1,150 $2,886 | 4 |
Dec 01, 2022
Added 30.3%
|